APHON Pediatric Chemotherapy-Biotherapy Renewal

Ngo, D., Patel, S., Kim, E. J., Brar, R., & Koontz, M. Z. (2015). Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature. Journal of Oncology Pharmacy Practice , 21 (4), 296–300. https://doi.org/10.1177/1078155214528018 Pastorelli, F., Derenzini, E., Plasmati, R., Pellegrini, C., Broccoli, A., Casadei, B., Argnani, L., Salvi, F., Pileri, S., & Zinzani, P. L. (2013). Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leukemia and Lymphoma , 54 (10), 2318–2321. https://doi.org/10.3109/10428194.2013.773997 Peddi, P. F., Peddi, S., Santos, E. S., & Morgensztern, D. (2014). Central nervous system toxicities of chemotherapeutic agents. Expert Review of Anticancer Therapy , 14 (7), 857–863. https://doi.org/10.1586/14737140.2014.911089 Ramli, N., Lim, C. H., Rajagopal, R., Tan, L. K., Seow, P., & Ariffin, H. (2020). Assessing changes in microstructural integrity of white matter tracts in children with leukaemia following exposure to chemotherapy. Pediatric Radiology , 50 (9), 1277–1283. https://doi.org/10.1007/s00247- 020-04717-x Robinson, K. E., Livesay, K. L., Campbell, L. K., Scaduto, M., Cannistraci, C. J., Anderson, A. W., Whitlock, J. A., & Compas, B. E. (2010). Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatric Blood and Cancer , 54 (4), 585–590. https://doi.org/10.1002/pbc.22362 Sioka, C., & Kyritsis, A. P. (2009). Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemotherapy and Pharmacology , 63 (5), 761–767. https://doi.org/10.1007/s00280-008-0876-6 Stein, A. S., Schiller, G., Benjamin, R., Jia, C., Zhang, A., Zhu, M., Zimmerman, Z., & Topp, M. S. (2019). Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: Management and mitigating factors. Annals of Hematology , 98 (1), 159–167. https://doi.org/10.1007/s00277-018-3497-0 Tian, Y., Gao, A., Wen, ., Wang, S., Zhang, S., Yang, X., Su, G., & Sun, Y. (2020). Immune-related neurological toxicities of PD-1/PD-L1 inhibitors in cancer patients: A systematic review and meta-analysis. Frontiers in Immunology , 11 , 595655. https://doi.org/10.3389/fimmu.2020.595655 Touat, M., Talmasov, D., Ricard, D., & Psimaras, D. (2017). Neurological toxicities associated with immune-checkpoint inhibitors. Current Opinion in Neurology , 30 (6), 659–668. https://doi.org/10.1097/WCO.0000000000000503 Verstappen, C. C., Heimans, J. J., Hoekman, K., & Postma, T. J. (2003). Neurotoxic complications of chemotherapy in patients with cancer: Clinical signs and optimal management. Drugs , 63 (15), 1549–1563. https://doi.org/10.2165/00003495-200363150-00003